Redesign Health
The company's agentic platform works to help pharmaceutical companies turn data into automated analyses, strategic insights and commercialization tools.
Leaders say AI will reshape jobs without replacing the human core of care.
Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
Industry leaders say 2025 marked AI’s shift from hype to practical impact, though the technology remains unready for full-scale adoption and ongoing concerns about ethics and bias persist.
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.
Some executives anticipate an acceleration of M&A activity as struggling startups seek exits, while others foresee more funding opportunities for companies with proven value in the sector.
Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.
Digital health leaders reveal the year's noteworthy events, including the rise in AI valuations, spike in demand for emergency contraception, realizations pertaining to LLMs and more.
Industry executives share their thoughts on the year's digital health developments - from an increased focus on women’s health to the rise of generative AI.